Introduction
The interest in this topic, "Who Should Provide Research Initiative and Support?", evolved from three observations: (1) The concern by reviewers of grant proposals related to epidemiological studies of low dose environmental effects: a fundamental question has been raised about the utility or the cost benefit of doing extensive low dose environmental epidemiological studies when the results of such studies are likely to be negative or equivocal. ( 2) The apparent desire to spend relatively large amounts of money to modify the environmental problems associated with low dose effects in the absence of solid evidence of health risks: the presumed effects on the population at risk is generally based on health effects at a much higher dose and the extrapolation of a dose re-*Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania 15261. December 1981 sponse curve to the low dose effect. ( 3) The relative decline in federal support for health related research and the corresponding increase dependency on support from special interest groups such as major industrial concerns, trade organizations, foundations, and lobbyists.
Several groups have recently discussed the need for epidemiological studies of environmental health effects. Some of my colleagues in toxicology and experimental biology have considered the mouse and rat a close relative to man and have decided that except for a slight weight adjustment, extrapolation from one species to another is biologically sound. Others have decided that cell culture techniques may be a satisfactory replacement for human observations. I do not believe that a dialogue about the merits of cell culture, mouse toxicological studies or even human clinical observations as compared to epidemiology is useful. Each approach has a specific merit and must be used conjointly in order to resolve the complex problems of the environment and human health. I 81 do, however, believe that the ultimate and important question is the relationship between a specific environmental agent and the exposed human, not necessarily the mouse. Human experimental studies, such as carefully done clinical trials, or even laboratory controlled experiments will remain the gem of the health research area. The success of the investigation is therefore based on: (1) that the specific disease can be identified, (2) that the incubation period from exposure to disease is relatively brief, and (3) that the common source accounts for a fairly substantial percentage of all disease being studied, that is, a high attributable risk. The contrast between the previously described investigation of a common source epidemic and many of the current environmental epidemiological studies is apparent. First, most of the environmental investigations begin with an exposure, rather than disease outbreak. The search is really for the epidemic, that is, disease rather than exposure. Fortunately most individuals exposed to a disease agent do not develop clinical disease. The so-called attack rate will rarely approach 100% unless the dose of the agent is very great or the pathogenicity of the agent, that is, ability to cause disease among those exposed, is severe. Most environmental investigations therefore require very large sample sizes in order to identify the relatively few individuals who will develop the disease given the exposure. Second, the incubation period from exposure to onset may be very long-measured in years, rather than days. The population must therefore be followed for long periods of time or we must resort to the classical historical perspective types of study de rather than specific diseases as an indicator of exposure. The increased prevalence of a marker is not proof of association with disease. The marker may be present long before clinical disease becomes apparent. Identification of the marker would substantially shorten the observed "incubation period" necessary for followup, and if the prevalence of the marker such as a chromosomal aberration is much higher than the ultimate disease, leukemia, the sample size would be substantially reduced. The cost of the study would be less even if the specific marker test is relatively expensive. The great hope for the epidemiologist is the identification of the steps from exposure to the biochemical change or cellular change to clinical disease. Unfortunately the history of the identification of early markers in relationship to subsequent disease has not been promising. Thus, in recent years, sputum cytology, CEA antigen and a-fetoprotein have not been as sensitive and specific as initially predicted.
The second question is, who pays the cost? The shrinking health research dollar and the inflationary costs of studies will certainly result in a decrease in both the number and scope of future investigations.
A large number of studies are being supported by other than the usual federal health research sources (Table 5 ). These include: (1) single industry or company financed occupational studies, (2) support from industry wide trade organization, such as the Electric Power Research Institute and the National Egg Board, (3) studies by foundations, and (4) studies initiated by labor unions and other consumer organizations.
Financial support for environmental research from any of these sources have certain restrictions. Industry support is obviously goal-specific.
The industry or company, such as a steel company, is interested in determining the potential health hazards related to a specific exposure within the industry. The recent explosion in industrial epidemiological studies seems to be generated by a desire to stay at least one step ahead of NIOSH and OSHA regulations and the numerous criteria statements which are being published. Excellent industry-supported studies have been done especially here at the Graduate School of Public Health in the Department of Biostatistics and Industrial and Environmental Health Sciences. Unfortunately the support of these studies is some times predicated on the interest of the company and not necessarily on the specific merits of the issues. Most of these studies have also been limited in their scope to reviews of occupational records and mortality followup. Recently there has become a tendency for companies to acquire their own "inhouse epidemiologist" as a way of better controlling the output and cost. Such an approach, if it continues, could clearly lead to biased studies whether intended or not. Few of these studies will probably expand beyond the company population, due to publication restrictions once a particular problem with these studies has been deduced, at least in those studies being conducted by university groups.
Support of research by so called industrial trade organizations is also apparently growing in popularity. The "consumer" or industrial producer is taxed a smaller amount of money which is then marked for research usually related to the industrial product. The Electric Power Research Institute apparently has a small hidden tax on electric bills. The National Egg Board collects money based on the shipments of crates of eggs. This approach to collecting research funds has certain merits that will be discussed later. A relatively large amount of funds can be generated at a minimal cost to any single individual. The funds can generally be utilized for goal-directed important research of particular interest to both the company and the consumer. The basic problem again is that this type of research tends to be very goal-specific as defined by the industrial organization and is often tailored to the specific value of the products. The Egg Board research, for example, has come under considerable scrutiny because of the belief that the research is primarily aimed at proving the value of the egg yolk. It is unlikely that the research supported by the Electric Power Research Institute is oriented primarily at turning on light switches. However, the research is generally not investigator-oriented and therefore in some way may stifle the intellect of the investigative research community. Also this research tends to be short term as compared to the necessary long term epidemiological studies often necessary for major environmental problems.
The foundations have played a role in public health research and teaching. The Rockefeller Foundation was responsible for the early development of public health schools in the United States. The work of the National Foundation for Infantile Paralysis in the development of the Salk vaccine is well known. The Mellon Foundation supported the development of the University of Pittsburgh Graduate School of Public Health. Foundation support will probably continue to play a vital role in public health and in environmental research. However, foundation support is often short term and subject to the vagaries of the "board of directors" or review committee.
Finally, pressure from labor unions and consumer organizations has resulted in another source of support for environmental research. In this case as part of a labor agreement a certain amount of funds are set aside for research into a specific problem. Again, the research is very goal-specific, often related to a specific company or industry, and not a general environmental problem.
The above sources of research support will continue to play a major role in environmental research. I believe, however, that the major source of support will continue to depend on the federal research program, such as the National Institutes of Health, Environmental Protection Agency, and the National Institute of Occupation, Safety and Health. There are several reasons for these assumptions. First, as noted, much of the funds from the other sources are generally restricted to specific industry and occupational groups. Second, are usually very goal specific, that is a contract to do a specific job, and thirdly, of relatively short duration. It is doubtful whether major environmental research programs within universities, or other health centers can survive strictly on such funds.
Continued federal support for our environmental epidemiological research is obviously related to the quality of the research proposals and the availability of the funds. Two aspects of study designs have recently created very thorney problems for the support of these studies.
The first problem has also been previously discussed and relates to the inability to measure the individual's exposure. Many of the earlier environmental studies were of the so-called ecological type, in which the distributions of rates within a community or over time were compared in relationship to estimated environmental exposures. As noted, it is unlikely that such studies will resolve the low dose-effect problem. They are all 86 confounded by numerous other differences between the communities, as well as difficulties in estimating doses within defined populations. The occupational longitudinal studies have also provided relatively crude estimates of exposure dose. Support for future epidemiological studies of low dose effects will probably require a better estimate of environmental exposure especially low dose effects. This will include more careful measurements of the occupational, community, and home environmental exposures. Occupational epidemiological studies will require good industrial hygiene measurement. Better estimates of air and water pollutants will be required, and at least some sampling by personal monitoring of the environment will probably be necessary. The measurement of the home environment that is indoor pollution will probably be an extremely difficult and complex problem.
The second concern has also been briefly mentioned in the introduction. Studies of low dose effects, even with relatively large sample sizes and adequate power, have a good chance of failing to demonstrate any adverse effect (Table 4) . Some investigators seem to panic at the thoughts of an expensive "negative" study. One federal agency has gone as far as to basically decide that negative epidemiological studies are of little value. Basically, if you don't have a positive result you're fired! Scientific review groups responsible for allocation of funds are not easily disposed to supporting low dose effect studies that have a high probability of finding no effects. It does seem to me that there is an important place for such studies. Many citizens are frightened by the potential health effects of low level environmental exposure. For example, small increases in radiation exposure, such as been noted in Cannonsburg, near Pittsburgh, or in relationship to Three Mile Island, have conjured up the fear of many cases of leukemia, cancer, congenital malformations and developmental abnormalities. Some individuals feed this fear with inaccurate data and numerous press reports. Newspaper reporters unable to obtain data from available studies often publish preliminary and inaccurate information and add to the citizens' concern. The hysteria associated with the reporting of the exposure probably has a far greater health effect on the public than the potential low dose physical effect. The ability to determine clearly the estimated health impact from low dose effect would be extremely important for the physical as well as mental health of the population. The study designs to test these low dose effects must be biologically sound. The length of followup has to be adequate to cover the proposed incubation period. The Environmental Health Perspectives estimation of dose must be reasonably determined both within the exposed population and between the exposed and controls. The sample size should be large enough given an estimated relative risk to have at least a reasonably good power. The relative risk estimates should be based on the best current available data. These studies are very expensive and I believe will not be supported by currently available federal research dollars. We will therefore be left with three choices: (1) to accept the fact that low dose epidemiological studies are not cost-effective and accept toxicological, animal experimental and the mathematical extrapolation from high dose studies in humans, (2) One of the growing problems with these types of studies is the confidentiality questions that are increasingly limiting the investigators to the available data sources, such as mortality statistics, incidence data, hospital records, birth certificates, etc. One always wonders how John Snow would have responded if the water company and health department had told him that their records were confidential. We recently had an experience in which the gas company told us that the date in which a home was switched from coal burning to natural gas was confidential.
Finally, a more adequate source of funding is necessary. If it is logical to tax the consumer for electric power and use the funds to support the Electric Power Research Institute, and for the Egg Board to tax each crate of eggs, then producer-related health research taxes might be considered. The obvious approach would be a tax on the sources of environmental pollution or on known health hazards. A tax on certain industrial processes known to cause pollution in the environment might be considered inflationary and also likely to decrease the competitive position of an American industry. The steel industry is reported to be in deep trouble already and would probably be quite unhappy if an additional tax were added to their product, even if relatively modest, especially if the funds were used for research not directly related to the industry. The use of fines for pollution as a source of health research would be unstable and also might lead to more enforcements in order to obtain more money. The old speed trap towns would be replaced by the environmental monitoring patrol.
A tax on dangerous consumer products would have certain appeal (Table 6 ). Cigarette smoking is probably the single largest source of personal environmental pollution. Representative Drinan recently introduced legislation to add a 10 cent tax to cigarettes. He estimated a yield of about $4-5,000,000,000. My own estimates which were conceived prior to his announcement were more conservative, about $2,500,000,000. He apparently proposes the use of such funds for both health care and research. I think a more realistic use of such funds would be for health-related research. The unfortunate victim of smoking related diseases will probably benefit more from health research than payment for ineffective treatment.
Excess consumption of alcohol along with cigarette smoking are the major sources of many diseases in this country. The estimated revenue from a $1 tax based on a gallon of alcohol would be $500,000,000 per year. This would be the equivalent of a 0.2 cent tax on a bottle of beer. These two sources of funding could lead to a major expansion of public health efforts in the United States. They could lead to a better understanding of the relationship between various environmental factors, health and disease.
In summary, changes in environmental epidemiological research are necessary. These include: (1) support for primary investigator initiated research, (2) better measurement of the environment and disease, (3) great emphasis on case-control and investigations of epidemics and (4) a better and more stable source of funding.
